Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Neogen launches coconut food allergen test kits


LANSING, Mich., March 25, 2019 /PRNewswire/ -- Neogen's comprehensive line of tests to detect allergens in food products before they can reach consumers now includes simple and accurate tests for coconut in food, beverages and environmental samples. 

Neogen's new Reveal® 3-D for Coconut Allergen screens environmental and liquid samples at 1 part per million (ppm) in only 5 minutes. The new Veratox® for Coconut Allergen provides precise results in the range of 1 to 25 ppm for testing food and beverage samples. 

"The addition of our tests for coconut adds to Neogen's leadership role in providing food allergen testing solutions," said John Adent, Neogen's president and chief executive officer. "Ever since we developed the first commercially available rapid test for a food allergen, now 20 years ago, we have provided our testing customers with their best options to protect their food allergic consumers. These new tests will enable our customers to use the same easy-to-use testing methodology to test for the allergens of most concern to the food industry."

Neogen also offers screening and quantitative food allergen test kits for foods identified by the Food and Drug Administration (FDA) as being of the most concern, including tests to detect tree nuts (e.g., almond, hazelnut, pecan, walnut, cashew and pistachio), eggs, wheat/gluten, milk, peanuts, soy and crustacea (e.g., crab, lobster and shrimp), and several others.

Neogen's Reveal 3-D format features three test lines, including an overload detection system designed to ensure highly positive samples are accurately reported. The test screens at 1 ppm coconut protein in environmental samples, clean-in-place (CIP) rinses, ultra-high temperature (UHT) processed beverages, and other beverages (e.g., coconut water, sports drinks, milk and enhancers).

The Veratox test is a sandwich enzyme-linked immunoassay (S-ELISA) that requires minimal training and standard laboratory equipment to produce quantitative results in only 30 minutes following extraction. The test provides a method of easily determining if an ingredient or product has been subject to cross-contact with coconut.

Neogen Corporation (NASDAQ: NEOG) develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in worldwide biosecurity products, animal genomics testing and the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals and veterinary instruments.

CONTACT:  

Jennifer Baker, Neogen Corporation


517/372-9200, [email protected]

 

SOURCE Neogen Corporation


These press releases may also interest you

at 05:10
Neurology Devices: Global Markets is basically a detailed study or report about the worldwide market for medical tools used in treating neurological conditions. These devices could be anything from equipment that helps stimulate the nervous system to...

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...



News published on and distributed by: